Ved S, Montag M, Schmutzler A, Prietl G, Haidl G, van der Ven H
Department of Endocrinology and Reproductive Medicine, University of Bonn, Germany.
Andrologia. 1997 Sep-Oct;29(5):241-2. doi: 10.1111/j.1439-0272.1997.tb00477.x.
The success of intracytoplasmic sperm injection (ICSI) is poor when only immotile spermatozoa can be retrieved. In a couple with complete male asthenozoospermia the possible use of the hypo-osmotic swelling test to select spermatozoa for microinjection was examined. Following incubation in hypo-osmotic medium (Hypo 10, IVF Science, Göteborg, Sweden), 26% of immotile spermatozoa showed signs of sperm swelling (HOS-positive). After injection of HOS-positive spermatozoa, 5 out of 12 oocytes fertilized (41%) and after transfer of three embryos a healthy singleton pregnancy was achieved. In a previous ICSI cycle of this couple without preselection of spermatozoa by the HOS test, only 1 out of 10 oocytes fertilized. It is concluded that selection of spermatozoa by hypo-osmotic swelling-test prior to sperm microinjection seems to be a valuable tool to increase the fertilization rate in cases with complete asthenozoospermia.
当只能获取到不活动精子时,胞浆内单精子注射(ICSI)的成功率较低。在一对男性完全弱精子症的夫妇中,研究了使用低渗肿胀试验来选择用于显微注射的精子的可能性。在低渗培养基(Hypo 10,IVF Science,哥德堡,瑞典)中孵育后,26%的不活动精子显示出精子肿胀迹象(HOS阳性)。注射HOS阳性精子后,12个卵母细胞中有5个受精(41%),在移植3个胚胎后实现了单胎健康妊娠。在这对夫妇之前未通过HOS试验预选精子的ICSI周期中,10个卵母细胞中只有1个受精。结论是,在精子显微注射前通过低渗肿胀试验选择精子似乎是提高完全弱精子症病例受精率的一种有价值的方法。